AI SummaryIndia's pharmaceutical quality crisis is acute — Tripura's 62 NSQ medicines crackdown in March 2026 reflects a nationwide testing bottleneck. The market for independent, accredited pharma testing labs is estimated at ₹500–800 crore annually, yet only ~50 NABL-certified labs exist nationally. Entrepreneurs with pharma/chemistry backgrounds and ₹1.5–2.5 crore capital should establish labs in underserved Tier-2 cities (Indore, Nagpur, Lucknow, Chandigarh) to capture ₹10–50 lakh monthly revenue per 50–100 daily samples. Regulatory tailwinds and supplier desperation make 2026 an optimal entry point.
Loading...